The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain

Anaerobe

Volumn 36, Issue , 2015, Pages 49-52

  Zhang, Keshan ^a,b   Zhao, Song ^a,d   Wang, Yuankai ^a   Zhu, Xuejun ^d   Shen, Hong ^d   Chen, Yugen ^d   Sun, Xingmin ^a,c  

^a TUFTS UNIVERSITY   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL SPORE; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE CD37; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; ANIMAL; ANTIBIOSIS; BIOSYNTHESIS; C57BL MOUSE; CLASSIFICATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENETICS; HUMAN; MICROBIOLOGY; PHYSIOLOGY;

BACTERIAL TOXIN;

ANIMALS; ANTIBIOSIS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MICE; MICE, INBRED C57BL;

EID: 84945302337     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.09.009     Document Type: Article

References (33)

1. Barbut F., Corthier G., Charpak Y., Cerf M., Monteil H., Fosse T., Trevoux A., De Barbeyrac B., Boussougant Y., Tigaud S., et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch. Int. Med. 1996, 156(13):1449-1454.
2. Elliott B., Chang B.J., Golledge C.L., Riley T.V. Clostridium difficile-associated diarrhoea. Int. Med. J. 2007, 37(8):561-568.
3. Kelly C.P., Pothoulakis C., LaMont J.T. Clostridium difficile colitis. N. Engl. J. Med. 1994, 330(4):257-262.
4. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 2005, 18(2):247-263.
5. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173(9):1037-1042.
6. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., Bourgault A.M., Nguyen T., Frenette C., Kelly M., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005, 353(23):2442-2449.
7. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., Johnson S., Gerding D.N. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005, 353(23):2433-2441.
8. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7(7):526-536.
9. Shim J.K., Johnson S., Samore M.H., Bliss D.Z., Gerding D.N. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998, 351(9103):633-636.
10. Songer J.G., Jones R., Anderson M.A., Barbara A.J., Post K.W., Trinh H.T. Prevention of porcine Clostridium difficile-associated disease by competitive exclusion with nontoxigenic organisms. Vet. Microbiol. 2007, 124(3-4):358-361.
11. Villano S.A., Seiberling M., Tatarowicz W., Monnot-Chase E., Gerding D.N. Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects. Antimicrob. Agents Chemother. 2012, 56(10):5224-5229.
12. Nagaro K.J., Phillips S.T., Cheknis A.K., Sambol S.P., Zukowski W.E., Johnson S., Gerding D.N. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob. Agents Chemother. 2013, 57(11):5266-5270.
13. Smith C.J., Markowitz S.M., Macrina F.L. Transferable tetracycline resistance in Clostridium difficile. Antimicrob. Agents Chemother. 1981, 19(6):997-1003.
14. Brouwer M.S., Allan E., Mullany P., Roberts A.P. Draft genome sequence of the nontoxigenic Clostridium difficile strain CD37. J. Bacteriol. 2012, 194(8):2125-2126.
15. Sun X., Wang H., Zhang Y., Chen K., Davis B., Feng H. Mouse relapse model of Clostridium difficile infection. Infect. Immun. 2011, 79(7):2856-2864.
16. Czuprynski C.J., Johnson W.J., Balish E., Wilkins T. Pseudomembranous colitis in Clostridium difficile-monoassociated rats. Infect. Immun. 1983, 39(3):1368-1376.
17. Fekety R., Silva J., Toshniwal R., Allo M., Armstrong J., Browne R., Ebright J., Rifkin G. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev. Infect. Dis. 1979, 1(2):386-397.
18. Knoop F.C. Clindamycin-associated enterocolitis in guinea pigs: evidence for a bacterial toxin. Infect. Immun. 1979, 23(1):31-33.
19. Steele J., Feng H., Parry N., Tzipori S. Piglet models of acute or chronic Clostridium difficile illness. J. Infect. Dis. 2010, 201(3):428-434.
20. Chen X., Katchar K., Goldsmith J.D., Nanthakumar N., Cheknis A., Gerding D.N., Kelly C.P. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008, 135(6):1984-1992.
21. Douce G., Goulding D. Refinement of the hamster model of Clostridium difficile disease. Methods Mol. Biol. 2010, 646:215-227.
22. Killgore G., Thompson A., Johnson S., Brazier J., Kuijper E., Pepin J., Frost E.H., Savelkoul P., Nicholson B., van den Berg R.J., et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 2008, 46(2):431-437.
23. Perez J, Springthorpe VS, Sattar SA: Clospore: a liquid medium for producing high titers of semi-purified spores of Clostridium difficile. Journal of AOAC International, 94(2):618-626.
24. Evans C.T., Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile Infection. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2015, 60(Suppl. 2):S66-S71.
25. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2007, 45(3):302-307.
26. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., Petit J.C. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 2000, 38(6):2386-2388.
27. Tonna I., Welsby P.D. Pathogenesis and treatment of Clostridium difficile infection. Postgrad. Med. J. 2005, 81(956):367-369.
28. Seal D., Borriello S.P., Barclay F., Welch A., Piper M., Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur. J. Clin. Microbiol. 1987, 6(1):51-53.
29. Gerding D.N., Meyer T., Lee C., Cohen S.H., Murthy U.K., Poirier A., Van Schooneveld T.C., Pardi D.S., Ramos A., Barron M.A., et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. Jama 2015, 313(17):1719-1727.
30. Nagaro KJ, Phillips ST, Cheknis AK, Sambol SP, Zukowski WE, Johnson S, Gerding DN: Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrobial Agents and Chemotherapy, 57(11):5266-5270.
31. Fischer W.A., Chason K.D., Brighton M., Jaspers I. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. Vaccine 2014, 32(15):1761-1767.
32. Wang Z., Wu Q. Research progress in live attenuated Brucella vaccine development. Curr. Pharm. Biotechnol. 2013, 14(10):887-896.
33. Brouwer M.S., Roberts A.P., Hussain H., Williams R.J., Allan E., Mullany P. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers. Nat. Commun. 2013, 4:2601.